Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	1.32	1.92	3.51	0.05	0.04	0.32
Cash & Short-Term Investments	1.32	1.92	3.51	0.05	0.04	0.32
Cash Growth	-41.85%	-45.30%	7065.35%	25.64%	-87.74%	-
Accounts Receivable	143.49	123.72	46.93	69.98	70.1	75.65
Other Receivables	-	-	-	0.02	0.02	0.06
Receivables	150.53	126.78	47.27	70.01	70.12	75.7
Inventory	80.3	51.43	30.51	25.71	7.47	2.06
Other Current Assets	32.29	21.09	6.97	1.59	0.61	2
Total Current Assets	264.44	201.22	88.27	97.36	78.24	80.08
Property, Plant & Equipment	158.98	154.36	153.1	155.17	59.49	33.62
Long-Term Investments	-	0.05	1.25	-	-	-
Long-Term Deferred Tax Assets	0.27	0.54	0.09	0.08	-	-
Other Long-Term Assets	-0	0.39	0.4	0.43	0.93	1.86
Total Assets	424.01	356.56	243.11	253.04	138.67	115.57
Accounts Payable	25.17	37.73	11.26	24.81	8.37	9.25
Accrued Expenses	4.04	1	0	1.18	0.47	0.1
Short-Term Debt	122.47	39.3	47.39	35.56	28.8	27.76
Current Portion of Long-Term Debt	-	-	-	8.32	10.28	6.9
Current Income Taxes Payable	-	4.66	1.2	4.33	-	0.2
Other Current Liabilities	0.11	11.98	59.72	0.05	0.02	-
Total Current Liabilities	151.78	94.67	119.56	74.26	47.95	44.2
Long-Term Debt	69.69	69.03	65.11	122.48	58.55	52.12
Long-Term Deferred Tax Liabilities	-	-	-	-	0.06	0.25
Total Liabilities	221.51	163.7	184.67	196.73	106.56	96.56
Common Stock	77.57	77.57	53.57	56.31	32.11	19.01
Additional Paid-In Capital	-	96	-	-	-	-
Retained Earnings	-	19.28	4.87	-	-	-
Shareholders' Equity	202.49	192.86	58.44	56.31	32.11	19.01
Total Liabilities & Equity	424.01	356.56	243.11	253.04	138.67	115.57
Total Debt	192.15	108.33	112.49	166.36	97.63	86.77
Net Cash (Debt)	-190.83	-106.41	-108.98	-166.31	-97.59	-86.45
Net Cash Per Share	-24.70	-13.73	-18.03	-31.04	-18.22	-16.14
Filing Date Shares Outstanding	7.77	7.76	5.36	5.36	5.36	5.36
Total Common Shares Outstanding	7.77	7.76	5.36	5.36	5.36	5.36
Working Capital	112.67	106.55	-31.3	23.11	30.29	35.89
Book Value Per Share	26.05	24.86	10.91	10.51	5.99	3.55
Tangible Book Value	202.49	192.86	58.44	56.31	32.11	19.01
Tangible Book Value Per Share	26.05	24.86	10.91	10.51	5.99	3.55
Land	-	139.65	139.65	139.64	40.92	9.97
Buildings	-	2.57	-	-	-	-
Machinery	-	16.89	15.9	34.35	34.1	35.21

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.